Nanobiotechnology in Diagnosis, Drug Delivery and Treatment. Группа авторов

Читать онлайн.
Название Nanobiotechnology in Diagnosis, Drug Delivery and Treatment
Автор произведения Группа авторов
Жанр Химия
Серия
Издательство Химия
Год выпуска 0
isbn 9781119671862



Скачать книгу

      Superparamagnetic iron oxide nanoparticles (SPIONs) are well known as MRI contrast agents for the study of the pathologically changed tissues, e.g. tumors or atherosclerotic plaque. They can be functionalized with various biomolecules (e.g. hormones, antibodies, cyclic tripeptides) which improve their bioavailability and interaction with specific tissues. Conjugation of SPIONs with biomolecules affecting their binding to the receptors of cancer cells or other types of internalization by cells and strong accumulation of these conjugates in the pathologically changed tissues, e.g. tumors. Therefore, it allows to detect tumors and enhance the negative contrast in the MRI (Chen et al. 2009; Meng et al. 2009; Kievit et al. 2012; Peiris et al. 2012; Bejarano et al. 2018). Similarly, iodinated polymer nanoparticles (Hyafil et al. 2007) or GNPs coated with polyethylene glycol (PEG) (Kim et al. 2007) have been developed as contrast agents for computed tomography (CT) imaging. Another imaging technique that benefits from nanoparticles as contrast agents is photoacoustic imaging, which detects the distribution of optical absorption within the organs (Li and Chen 2015).

      As mentioned above, diagnostic imaging techniques have certain limitations, therefore multimodal nanosystems have been developed to overcome these limitations. Multimodal nanosystems combine the properties of different nanoparticles with various imaging techniques for improved detection. These multimodal nanosystems use PET‐CT and PET‐MRI techniques that combine the sensitivity of positron emission tomography (PET) for metabolism imaging and tracking of labeled cells or cell receptors with the outstanding structural and functional characterization of tissues by MRI and the anatomical precision of CT. The lipid nanoparticles have been labeled with contrast agents and successfully employed in multimodal molecular imaging. These liposomes may be incorporated with gold, iron oxide, or quantum dot nanocrystals for CT, MRI, and fluorescence imaging, respectively (Rajasundari and Hamurugu 2011; Bejarano et al. 2018). Recently it was demonstrated that nanomaterials such as PdCu@Au nanoparticles radiolabeled with 64Cu and functionalized toward target receptors provided a tool for highly accurate PET imaging and photothermal treatment (Pang et al. 2016). Similarly, a 89Zr‐labeled liposome encapsulating a near‐infrared fluorophore was developed for both PET and optical imaging of cancer (Pérez‐Medina et al. 2015).

      Nanosensors use nanoparticles of different chemical nature: carbon nanomaterials (graphene, CNTs, carbon fibers, fullerenes, etc.) (Kurbanoglu and Ozkan 2018), nanoparticles of metals (gold, silver, copper, silicon; metal oxides; quantum dots) (Li et al. 2019), and branched polymers (dendrimers) (Abbasi et al. 2014). GNPs are used most often, due to their resistance to oxidation, low toxicity, and ability to amplify the biosensor signal. The application of such particles leads to increased sensitivity and detection limits up to one molecule (Vigneshvar et al. 2016). An important positive point of using nanosensors is also shorter assay time, especially when pathogenic microorganisms in food are detected. There are many reports available which involved the use of biosensors based on nanoparticles for screening for pathogens, toxins, and allergen products in food matrices (Warriner et al. 2014; Inbaraj and Chen 2016; Prakitchaiwattana and Detudom 2017).

Schematic illustration of similar colorimetric nanosensors.